No Data
No Data
Cerevel Therapeutics Holdings(CERE.US) Director Sells US$1.03 Million in Common Stock
$Cerevel Therapeutics Holdings(CERE.US)$ Director COLES N ANTHONY sold 25,000 shares of common stock on Jul 1, 2024 at an average price of $41.1814 for a total value of $1.03 million.Source: Announcem
Express News | Cerevel Therapeutics Shares Are Trading Lower Amid Unconfirmed Rumors of a Recommendation Memo From FTC Staff to Challenge the AbbVie Merger
Watching Cerevel Therapeutics; Traders Circulating M&A Blog Comments Saying A Recommendation Memo From The Staff At The FTC To "Challenge" The CERE/ABBV Merger Is Being Considered
Watching Cerevel Therapeutics; Traders Circulating M&A Blog Comments Saying A Recommendation Memo From The Staff At The FTC To "Challenge" The CERE/ABBV Merger Is Being Considered
Express News | U.S. FTC Sues To Block Tempur Sealy's Purchase Of Mattress Firm, Agency Says
Form 144 | Cerevel Therapeutics Holdings(CERE.US) Director Proposes to Sell 1.02 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jul 1, $Cerevel Therapeutics Holdings(CERE.US)$ Director NEAVELLE ANTHONY COLES intends to sell 25,000 shares of its common stock on Jul 1, with a total market value of approxi
Express News | Cerevel Therapeutics Shares Trading Higher Amid Circulation Of Rumors That The FTC Closed Door Meeting May Be About The Co's Merger With Tempur Sealy International